ClinicalTrials.govpublic full text
Bortezomib in Combination With CC-5013 in Patients With Relapsed/Refractory Multiple Myeloma
refractory multiple myeloma, relapsed multiple myeloma, multiple myeloma, bortezomib, revlimid, cc-5013, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 906049
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.